No connection

Search Results

ULY

BEARISH
$5.38 Live
Urgently Inc · NASDAQ
Target $6.75 (+25.5%)
$1.74 52W Range $17.99

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 22, 2026
Market cap
$11.79M
P/E
N/A
ROE
N/A
Profit margin
-15.8%
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
95%
ULY exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9 and a dangerously low Current Ratio of 0.34, indicating an inability to meet short-term obligations. While the stock has experienced a speculative 6-month price surge of 88.4%, the underlying fundamentals are catastrophic, with negative profit margins and negligible revenue growth (3.90%) for a technology firm. The extremely low Price/Sales ratio of 0.09 suggests the market is pricing in a high probability of insolvency or massive dilution. Despite a 'buy' recommendation from a small analyst sample, the deterministic health markers signal a high risk of failure.

Key Strengths

Recent reduction in quarterly EPS losses
Extremely low Price/Sales ratio (0.09) suggesting deep value if the company survives
Short-term positive price momentum (6M Change +88.4%)
Gross margin remains positive at 25.37%
Analyst target price ($6.75) is above current market price

Key Risks

Severe liquidity crisis with a Current Ratio of 0.34
Critical financial health as indicated by Piotroski F-Score of 1/9
Consistent failure to meet earnings estimates (1/4 beats in last 4 quarters)
Stagnant revenue growth (3.90% YoY) relative to technology sector peers
Micro-cap volatility and high risk of bankruptcy/insolvency

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
12
Weak
Value
20
Future
25
Past
10
Health
5
Dividend
0
AI Verdict
High Risk / Speculative
Key drivers: Critical liquidity shortage, Extreme Piotroski F-Score weakness, Negative profitability, Speculative price action decoupled from fundamentals
Confidence
90%
Value
20/100

P/S of 0.09 is typically a value signal, but in this health context, it is a value trap.

Positives
  • Very low P/S ratio
Watchpoints
  • No Graham Number due to lack of earnings
  • No Intrinsic Value support
  • P/E is negative
Future
25/100

Growth rates are insufficient to offset the burn rate.

Positives
  • Recent Q/Q EPS growth improvement
Watchpoints
  • Revenue growth (3.9%) is far below sector averages
  • Consistent earnings misses
Past
10/100

Long-term trend is overwhelmingly bearish.

Positives
  • Recent 6-month recovery
Watchpoints
  • 5-year price collapse of 92%
  • History of significant earnings surprises to the downside
Health
5/100

The company is in a state of financial emergency.

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score 1/9
  • Current Ratio 0.34
  • Quick Ratio 0.30
  • Negative ROA
Dividend
0/100

Dividend strength is 0/100.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • No capacity to pay dividends

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$5.38
Analyst Target
$6.75
Upside/Downside
+25.5%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ULY and closest competitors.

Updated 2026-04-21
ULY
Urgently Inc
Primary
5Y
-92.0%
3Y
-92.0%
1Y
+19.9%
6M
+88.4%
1M
+1.8%
1W
+0.5%
MSA
MultiSensor AI Holdings, Inc.
Peer
5Y
-98.5%
3Y
-98.6%
1Y
-83.3%
6M
-72.0%
1M
-49.0%
1W
-37.7%
TAO
Taoping Inc.
Peer
5Y
-99.9%
3Y
-99.4%
1Y
-80.3%
6M
-40.9%
1M
-12.2%
1W
+5.7%
JZ
Jianzhi Education Technology Group Company Limited
Peer
5Y
-99.8%
3Y
-97.6%
1Y
-88.1%
6M
-48.4%
1M
-4.8%
1W
-4.8%
CMB
Cambium Networks Corp
Peer
5Y
-99.8%
3Y
-99.4%
1Y
-62.1%
6M
-87.2%
1M
-91.1%
1W
-26.7%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
-7.08
PEG Ratio
N/A
P/B Ratio
N/A
P/S Ratio
0.09
EV/Revenue
0.54
EV/EBITDA
-15.35
Market Cap
$11.79M

Profitability

Profit margins and return metrics

Profit Margin -15.81%
Operating Margin -7.52%
Gross Margin 25.37%
ROE N/A
ROA -11.35%

Growth

Revenue and earnings growth rates

Revenue Growth +3.9%
Earnings Growth N/A
Q/Q Revenue Growth +3.94%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
0.34
Weak
Quick Ratio
0.3
Poor
Cash/Share
$2.51

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
26.3%
Op. Margin
-7.5%
Net Margin
-12.5%
Total Assets
$0.0B
Liabilities
$0.1B
Equity
$-0.0B
Debt/Equity
-1.94x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
168%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-03-13
$-1.97
+35.7% surprise
2025-11-12
$-3.63
-51.6% surprise
2025-08-12
$-4.5
-66.7% surprise
2025-05-13
$-4.69
-62.9% surprise

Technology Sector Comparison

Comparing ULY against 494 companies in the Technology sector (40 bullish, 167 neutral, 287 bearish)
Profit Margin
-15.81%
This Stock
vs
-12.58%
Sector Avg
+25.6% (Superior)
Revenue Growth
3.9%
This Stock
vs
5016.51%
Sector Avg
-99.9% (Slower)
Current Ratio
0.34
This Stock
vs
3.75
Sector Avg
-91.0% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

MICALI JAMES MICHAEL
Director
Stock Award
2026-01-28
833 shares
ZYNGIER ALEXANDRE
Director
Stock Award
2026-01-28
833 shares
DOMANIG GINA
Director
Stock Award
2026-01-28
833 shares
DORAN SUZIE
Director
Stock Award
2026-01-28
833 shares
POLLOCK RYAN
Director
Stock Award
2026-01-28
833 shares
Insider transactions can signal confidence or concerns about company prospects

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
2 analysts
Chardan Capital
2026-03-17
down
Buy Neutral
Chardan Capital
2025-11-13
Maintains
Buy Buy
Needham
2025-11-13
reit
Buy Buy

Past News Coverage

Recent headlines mentioning ULY from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI
Markets
Profile